Cargando…
An Optimized GD2-Targeting Retroviral Cassette for More Potent and Safer Cellular Therapy of Neuroblastoma and Other Cancers
Neuroblastoma is the commonest extra cranial solid cancer of childhood. Despite escalation of treatment regimens, a significant minority of patients die of their disease. Disialoganglioside (GD2) is consistently expressed at high-levels in neuroblastoma tumors, which have been targeted with some suc...
Autores principales: | Thomas, Simon, Straathof, Karin, Himoudi, Nourredine, Anderson, John, Pule, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816271/ https://www.ncbi.nlm.nih.gov/pubmed/27030986 http://dx.doi.org/10.1371/journal.pone.0152196 |
Ejemplares similares
-
Licensing of γδT cells for professional antigen presentation: A new role for antibodies in regulation of antitumor immune responses
por: Anderson, John, et al.
Publicado: (2012) -
Strategies for Targeting Retroviral Integration for Safer Gene Therapy: Advances and Challenges
por: Yoder, Kristine E., et al.
Publicado: (2021) -
Fluorescence-guided development of a tricistronic vector encoding bimodal optical and nuclear genetic reporters for in vivo cellular imaging
por: Badar, Adam, et al.
Publicado: (2015) -
Establishment and phenotyping of neurosphere cultures from primary neuroblastoma samples
por: Barton, Jack, et al.
Publicado: (2019) -
To become a more stronger and safer country
por: Lee, Jong-Koo
Publicado: (2023)